5 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Xeloda: new trials by email Literature Review of Xeloda trials Research Report on Xeloda
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment Fluorouracil injection, Xeloda - Colorectal Neoplasms, Breast Neoplasms | Phase 4 | Recruiting | Rutgers, The State University of New Jersey | 100 | 2025-08-27 | 2025-11-13 |
| Association of Capecitabine Pharmacokinetics and Toxicity With Aging Capecitabine - Breast Cancer, Colorectal Cancer | Phase 4 | Unknown | Newcastle-upon-Tyne Hospitals NHS Trust | 100 | 2016-05-01 | 2018-03-14 |
| Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma capecitabine - Adenocarcinoma of the Stomach | Phase 4 | Terminated | Cambridge University Hospitals NHS Foundation Trust | 13 | 2009-11-01 | 2015-07-21 |
| Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma capecitabine - Pancreatic Adenocarcinoma | Phase 4 | Completed | Cambridge University Hospitals NHS Foundation Trust | 13 | 2009-11-01 | 2013-02-18 |
| OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. bevacizumab [Avastin], Oxaliplatin, Xeloda - Colorectal Cancer | Phase 4 | Completed | Hoffmann-La Roche | 205 | 2008-02-01 | 2015-08-18 |
| A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer Capecitabine - Colorectal Cancer | Phase 4 | Completed | Hoffmann-La Roche | 63 | 2005-08-01 | 2016-11-02 |
| A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer Capecitabine, Bevacizumab - Breast Cancer | Phase 4 | Completed | Hoffmann-La Roche | 109 | 2005-06-01 | 2011-04-27 |
| A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer Capecitabine - Colorectal Cancer | Phase 4 | Completed | Hoffmann-La Roche | 28 | 2004-10-01 | 2016-11-02 |
Colorectal Neoplasms (5) · Breast Neoplasms (3) · Frailty (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Hoffmann-La Roche (4) · Cambridge University Hospitals NHS Foundation Trust (2) · Merck Sharp & Dohme LLC (1) · Newcastle-upon-Tyne Hospitals NHS Trust (1) · Rutgers, The State University of New Jersey (1)
Bulgaria (2) · United Kingdom (2) · United States (2) · Italy (1)
Duncan Jodrell, DM MSc FRCP (2) · Howard S. Hochster, MD (1)